Skip to main content
. 2023 Aug 1;15(8):2070. doi: 10.3390/pharmaceutics15082070
TME Tumor microenvironment
DEXs DC-derived exosomes
TAAs Tumor-associated antigens
TIME Tumor immune microenvironment
MVBs Multivesicular bodies
ILVs Intraluminal vesicles
ESCRT Endosomal Sorting Complex Required for Transport
VPS4 Vacular sorting protein 4
ALIX Apoptosis-linked gene 2-interacting protein X
HRS Hepatocyte growth factor-regulated tyrosine kinase substrate
STAM Signal transducing adaptor molecule
TEMs Tetraspanin-enriched microdomains
HSP Heat-shock protein family
FLOT Flotillin
EGFR Epidermal growth factor receptor
NKG2D Natural killer group 2 member D
ICAM-1 Intercellular cell adhesion molecule-1
TNF-α Tumor necrosis factor-α
PS Phosphatidylserine
LBPA Lysobisphosphatidic acid
NSCLC Non-small-cell lung cancer
DAMPs Damage-associated molecular paradigms
PAMPs Pathogen-associated molecular paradigms
CTL Cytotoxic T lymphocytes
MoDCs Monocyte-derived DCs
iNOS Inducible nitric oxide synthase
APCs Antigen-presenting cells
NKG2DL Natural killer group 2 member D ligands
LPS Lipopolysaccharide
IFN-γ Interferon-gamma
TRAIL Tumor necrosis factor-related apoptosis ligand
TLR4 Toll-like receptor 4
TLR1/2 Toll-like receptor 1/2
OVA Ovalbumin
BAG-6 BCL2-associated Athanogene 6
MAGE Melanoma-associated antigenic peptides
HCC Hepatocellular carcinoma
Treg Regulatory T cell
IL-10 Interleukin-10
TGF-β Transforming growth factor-β
Tsg101 Tumor susceptibility gene 101 protein
PD-L1 Programmed death-ligand 1